Genomic analysis and tracking of SARS-CoV-2 variants in Gwangju, South
Korea from 2020 to 2022
Abstract
Since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was
first reported in Wuhan, China in December 2019, it has spread rapidly,
and many coronavirus disease (COVID-19) cases have occurred in Gwangju,
South Korea. Viral mutations following the COVID-19 epidemic have
increased interest in the characteristics of epidemics in this region,
and pathogen genetic analysis is required for infection control and
prevention. In this study, SARS-CoV-2 whole-genome analysis was
performed on samples from patients with COVID-19 in Gwangju from 2020 to
2022 to identify the trends in COVID-19 prevalence and to analyze the
phylogenetic tree of dominant variants. B.41 and B.1.497 prevailed in
2020, the early stage of the COVID-19 outbreak; then, B.1.619.1 mainly
occurred until June 2021. B.1.617.2, classified as sublineage AY.69 and
AY.122, occurred continuously from July to December 2021. Since strict
measures to strengthen national quarantine management had been
implemented in South Korea until this time, mutations phylogenetic
analysis was also able to infer the epidemiological relationship between
infection transmission routes. Since the first identification of the
Omicron variant in late December 2021, the spread of infection has been
very rapid, and weekly whole-genome analysis of specimens has enabled us
to monitor new Omicron sublineage occurring in Gwangju. Our study
suggests that conducting reginal surveillance in addition to
nation-level genomic surveillance will enable more rapid and detailed
variant surveillance, which will be helpful in the overall prevention
and management of infectious diseases.